Collaboration to develop antibodies for cancer, autoimmune diseases announced.
Publication: Vaccine Weekly
Publication Date: 29-DEC-04
How to access the full article: Free access to all articles is available courtesy of your local library. To access the full article click the "See the full article" button below. You will need your US library barcode or password.
2004 DEC 29 - (NewsRx.com & NewsRx.net) -- Xencor announced a license and collaboration agreement with Genentech, Inc. (DNA) to create next-generation therapeutic antibodies for cancer and autoimmune diseases.
Under the terms of the agreement, Xencor will grant to Genentech an exclusive, worldwide license to use Xencor's XmAb technology...
Read the full article for free courtesy of your local library.
Bookmark this article
Print this article
Link to this article
Email this article
Digg It!
Add to del.icio.us
RSS
